Cargando…
The anti-cancer effects of itraconazole in epithelial ovarian cancer
We assessed the anti-proliferative activity of itraconazole using an EOC cell line (SKOV3ip1) and endothelial cell lines (HUVEC & SVEC4-10). We also examined angiogenesis (VEGFR2, p-ERK, p-PLCr1/2), hedgehog (Gli1, Ptch1, SMO), and mTOR (pS6K1) signaling pathways to determine the mechanism of ac...
Autores principales: | Choi, Chel Hun, Ryu, Ji-Yoon, Cho, Young-Jae, Jeon, Hye-Kyung, Choi, Jung-Joo, Ylaya, Kris, Lee, Yoo-Young, Kim, Tae-Joong, Chung, Joon-Yong, Hewitt, Stephen M., Kim, Byoung-Gie, Bae, Duk-Soo, Lee, Jeong-Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529373/ https://www.ncbi.nlm.nih.gov/pubmed/28747628 http://dx.doi.org/10.1038/s41598-017-06510-7 |
Ejemplares similares
-
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019) -
Perioperative administration of propranolol to women undergoing ovarian cancer surgery: A pilot study
por: Jang, Hye-In, et al.
Publicado: (2017) -
Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016) -
Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016) -
Single-site robotic surgery in gynecologic cancer: a pilot study
por: Yoo, Ha-Na, et al.
Publicado: (2015)